You are here

Why Us

Deans’ Message

AT THE FOREFRONT OF EDUCATION AND MEDICINE

Duke-NUS is greatly indebted to so many people and entities for making this enterprise an excellent one. Our enduring asset in making this journey a success has undoubtedly been our outstanding people and advocates. Their singular belief, commitment and perseverance to our common purpose have enabled the school to forge ahead in its endeavours.

We have also benefited from the strong support we continue to receive from our stakeholders and donors, many of whom are driven by the contributions we have made to the local and global medical scene.

As we move into the next decade, we are constantly reminded that healthcare practices and needs are always evolving and continually influencing medical education and research. Duke-NUS will continue to deepen its partnership with SingHealth and our partners to further integrate our strengths and enhance our Signature Research Programs, creating a world-class Academic Medical Centre in Singapore.

On 14 April 2005, Duke University and the National University of Singapore inked an agreement to establish the Duke-NUS Graduate Medical School in Singapore. Beyond being merely an excellent medical school based on the US model, Duke-NUS’ role and relevance in Singapore are much more encompassing.

Today, a decade on, we continue to achieve our mission of graduating well-trained clinicians and specialists to care for patients, as well as clinician researchers and clinician scientists who can contribute to the advancement of medical knowledge. We believe that this can only be achieved through the relentless pursuit of excellence in education, research and academic medicine, with a strong emphasis on collaboration and innovation.

Besides training medical students, Duke-NUS has also trained a burgeoning number of clinicians at SingHealth in research and teaching paedagogy, and made an impact on local school systems and organisations through our distinctive learning methodology. Designed at Duke-NUS in Singapore, TeamLEAD has not only redefined learning, but has also positively influenced schools in Singapore as well as our parent institution, Duke University, to adopt this innovative approach into their curriculum.

We have also firmly established five world-class Signature Research Programs (SRPs) in:

  • Cancer & Stem Cell Biology
  • Cardiovascular & Metabolic Disorders
  • Emerging Infectious Diseases
  • Neuroscience & Behavioural Disorders
  • Health Services & Systems Research

These areas were set up because they not only address the immediate, major health concerns of Singapore and the region, but also capitalise on Duke University’s research prowess. In a relatively short span of time, our researchers have made significant contributions in dengue, cancer and heart disease research with many more important research studies in the pipeline.

Backed by Duke University Health System’s strong experience and reputation in research, clinical care and education, Duke-NUS has partnered with Singapore’s biggest healthcare group to establish a formidable collaboration in academic medicine. The SingHealth Duke-NUS Academic Medical Centre builds on the collective clinical strengths of the SingHealth Group with Duke-NUS’ research and medical education capabilities. Together, we create a vibrant academic nexus for new discoveries, learning and care innovation – and bring it to where it matters most: our patients.

Duke-NUS is greatly indebted to so many people and entities for making this enterprise an excellent one. Our enduring asset in making this journey a success has undoubtedly been our outstanding people and advocates. Their singular belief, commitment and perseverance to our common purpose have enabled the school to forge ahead in its endeavours.

We have also benefited from the strong support we continue to receive from our stakeholders and donors, many of whom are driven by the contributions we have made to the local and global medical scene.

As we move into the next decade, we are constantly reminded that healthcare practices and needs are always evolving and continually influencing medical education and research.Duke-NUS will continue to deepen its partnership with SingHealth and our partners to further integrate our strengths and enhance our Signature Research Programs, creating a world-class Academic Medical Centre in Singapore.

Read the full Dean’s Message >>

At A Glance

Milestones

  • 2015 July

    Prof. Thomas Coffman named Dean at Duke-NUS

  • 2014 May

    Duke-NUS and SingHealth signed MOU to further affirm commitment to strengthening their Academic Medicine partnership

  • 2013 May

    Duke-NUS first fundraising Gala Dinner, graced by Singapore's President Tony Tan, raised over S$17 million for research and education initiatives

  • 2013 January

    Mr. Kai Nargolwala appointed Chairman of Duke-NUS's Governing Board

  • 2012

    Eight Duke-NUS faculty received the prestigious Singapore Translational Research (STaR) Investigator Awards, Clinician-Scientist Awards and Transition Awards

  • 2011

    First MD class completed medical training and embarked on residency training in hospitals and national institutes

  • 2010

    The inaugural cohort from the PhD program in Integrated Biology and Medicine enrolled

  • 2009

    Singapore's Prime Minister Lee Hsien Loong officially opened the campus at 8 College Road

  • 2008

    Lien Centre for Palliative Care launched

  • 2007

    First class of MD students enrolled

  • 2006

    Received first gift of S$80 million from the estate of Tan Sri Khoo Teck Puat, to grow its biomedical research initiatives

  • 2005 August

    Duke-NUS commenced operations from an interim campus

  • 2005 April

    Duke University and NUS formalised the first phase of a partnership to proceed with Singapore's first US-style medical school, named Duke-NUS Medical School

  • 2003

    Duke University and National University of Singapore (NUS) signed a Memorandum of Understanding (MOU) to set up a graduate medical school in Singapore

  • 2002

    Led by then-Deputy Prime Minister Dr. Tony Tan, a ministerial delegation visited several US universities to discuss a partnership in Singapore

  • 2001

    An MOE-appointed international Medical Education Review Panel recommended that Singapore sets up a graduate medical school to develop highly-trained clinicians and clinician scientists to support Singapore's Biomedical Sciences Initiative

  • 2000

    Singapore launched S$3-billion Biomedical Sciences Initiative to help the country become Asia’s biomedical hub

About Duke-NUS

Duke-NUS commits every gift to the most promising research and education programs to find cures, transform medicine and improve patients' lives.

Keep In Touch

 

Get Map

 

Follow Us!